Pharming Group N.V.

NasdaqGM:PHAR Stock Report

Market Cap: US$1.2b

Pharming Group Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Fabrice Chouraqui

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

Pharming Group: Small Dutch Company With Strong Revenues

Apr 01

Pharming's rare immunodeficiency disorder drug gets FDA priority review

Sep 28

Pharming gets EMA panel nod for accelerated review of leniolisib for rare immunodeficiency disorder

Aug 01

CEO

Fabrice Chouraqui

less than a year
Tenure

Mr. Fabrice Chouraqui, Ph D., PharmD, serves as the Chief Executive Officer and Executive Director of Pharming Group N.V. since March 4, 2025. He served as the Chief Executive Officer at Cellarity, Inc. si...

Leadership Team

NamePositionTenureCompensationOwnership
Fabrice Chouraqui
CEO & Executive Directorless than a yearno datano data
Kenneth Lynard
Chief Financial Officerless than a yearno datano data
Mireille Sanders
Chief Operations Officer6.4yrsno data0.14%
$ 1.7m
Susanne Embleton
Investor Relations Managerno datano datano data
Ruud Van Outersterp
Chief Legal & Compliance Officer4.7yrsno data0.075%
$ 913.8k
Michael Levitan
VP of Investor Relations & Corporate Communicationsno datano datano data
Ines Bernal
Chief People Officer1.1yrsno data0.0092%
$ 112.2k
Anurag Relan
Chief Medical Officer4.6yrsno data0.11%
$ 1.3m
Alexander Breidenbach
Chief Business Officer2.3yrsno data0.017%
$ 205.9k
Leverne Marsh
Chief Commercial Officerno datano datano data
Bruno M. Giannetti
Consultant4.6yrsno datano data
2.3yrs
Average Tenure
59yo
Average Age

Experienced Management: PHAR's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Fabrice Chouraqui
CEO & Executive Directorless than a yearno datano data
Leonard Kruimer
Independent Non-Executive Director4.7yrsUS$104.00k0.022%
$ 271.3k
Mark Pykett
Independent Non-Executive Vice Chairman5.1yrsUS$95.00k0.026%
$ 315.4k
Barbara Yanni
Independent Non-Executive Director5.1yrsUS$109.00k0.026%
$ 315.4k
Richard Peters
Non-Executive Chairman of Board2.3yrsUS$154.00k0.015%
$ 186.2k
Elaine Sullivan
Non Executive Directorless than a yearno data0.0031%
$ 37.6k
Jabine T. M. van Meijs
Independent Non-Executive Director4.7yrsUS$109.00k0.022%
$ 271.3k
4.7yrs
Average Tenure
63.5yo
Average Age

Experienced Board: PHAR's board of directors are considered experienced (4.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/01/13 20:19
End of Day Share Price 2026/01/13 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Pharming Group N.V. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John SavinEdison Investment Research
Simon ScholesFirst Berlin Equity Research GmbH
Joseph PantginisH.C. Wainwright & Co.